Furthermore, in 2019, Singh et al. reported that by using UroA as a treatment on LPS-induced peritonitis in the C57BL/6 mice model, it significantly reduces the serum IL-6 and TNF-α levels. The gene discussed is TNF; the disease is peritonitis.